Granulocyte Macrophage Colony-stimulating Factor Has Come of Age: From a Vaccine Adjuvant to Antiviral Immunotherapy

Overview

Journal Cytokine Growth Factor Rev

Date 2021 Feb 17

PMID 33593661

Citations 31

Authors

Maria Petrina

Jacqueline Martin

Sameh Basta

Affiliations

Soon will be listed here.

Abstract

GM-CSF acts as a pro-inflammatory cytokine and a key growth factor produced by several immune cells such as macrophages and activated T cells. In this review, we discuss recent studies that point to the crucial role of GM-CSF in the immune response against infections. Upon induction, GM-CSF activates four main signalling networks including the JAK/STAT, PI3K, MAPK, and NFκB pathways. Many of these transduction pathways such as JAK/STAT signal via proteins commonly activated with other antiviral signalling cascades, such as those induced by IFNs. GM-CSF also helps defend against respiratory infections by regulating alveolar macrophage differentiation and enhancing innate immunity in the lungs. Here, we also summarize the numerous clinical trials that have taken advantage of GM-CSF's mechanistic attributes in immunotherapy. Moreover, we discuss how GM-CSF is used as an adjuvant in vaccines and how its activity is interfered with to reduce inflammation such as in the case of COVID-19. This review brings forth the current knowledge on the antiviral actions of GM-CSF, the associated signalling cascades, and its application in immunotherapy.

Citing Articles

Advanced progress in the genetic modification of the oncolytic HSV-1 virus.

Zhou M, Shen Z Front Oncol. 2025; 14:1525940.

PMID: 39906660 PMC: 11790444. DOI: 10.3389/fonc.2024.1525940.

The association of maternal COVID-19-infection during pregnancy on the neonatal immune profile and associations with later diagnosis of neurodevelopmental disorders.

Kim D, Croen L, Iosif A, Ames J, Alexeeff S, Qian Y Brain Behav Immun. 2024; 123:1071-1080.

PMID: 39532198 PMC: 11684471. DOI: 10.1016/j.bbi.2024.11.014.

Benzo (A) pyrene exposure alters alveolar epithelial and macrophage cells diversity and induces antioxidant responses in lungs.

Chauhan P, Bhardwaj N, Rajaura S, Chandra H, Singh A, Babu R Toxicol Rep. 2024; 13:101777.

PMID: 39506978 PMC: 11539143. DOI: 10.1016/j.toxrep.2024.101777.

Present and Future of Immunotherapy for Triple-Negative Breast Cancer.

Sriramulu S, Thoidingjam S, Speers C, Nyati S Cancers (Basel). 2024; 16(19).

PMID: 39409871 PMC: 11475478. DOI: 10.3390/cancers16193250.

Evaluation of the immune responses of biological adjuvant bivalent vaccine with three different insertion modes for ND and IBD.

Sun W, Li S, Niu D, Qin R, Li H, Xue Z Virulence. 2024; 15(1):2387181.

PMID: 39101682 PMC: 11302549. DOI: 10.1080/21505594.2024.2387181.

References

Lee M, Lacey D, Fleetwood A, Achuthan A, Hamilton J, Cook A . GM-CSF- and IRF4-Dependent Signaling Can Regulate Myeloid Cell Numbers and the Macrophage Phenotype during Inflammation. J Immunol. 2019; 202(10):3033-3040. DOI: 10.4049/jimmunol.1801549. View

Cakarova L, Marsh L, Wilhelm J, Mayer K, Grimminger F, Seeger W . Macrophage tumor necrosis factor-alpha induces epithelial expression of granulocyte-macrophage colony-stimulating factor: impact on alveolar epithelial repair. Am J Respir Crit Care Med. 2009; 180(6):521-32. DOI: 10.1164/rccm.200812-1837OC. View

de Groot R, Coffer P, Koenderman L . Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cell Signal. 1998; 10(9):619-28. DOI: 10.1016/s0898-6568(98)00023-0. View

Tuttle D, Harrison J, Anders C, Sleasman J, Goodenow M . Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J Virol. 1998; 72(6):4962-9. PMC: 110058. DOI: 10.1128/JVI.72.6.4962-4969.1998. View

Burmester G, McInnes I, Kremer J, Miranda P, Korkosz M, Vencovsky J . A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis. Ann Rheum Dis. 2017; 76(6):1020-1030. DOI: 10.1136/annrheumdis-2016-210624. View

Huang F, Barnes P, Feng Y, Donis R, Chroneos Z, Idell S . GM-CSF in the lung protects against lethal influenza infection. Am J Respir Crit Care Med. 2011; 184(2):259-68. PMC: 6938174. DOI: 10.1164/rccm.201012-2036OC. View

Palumbo P, Raskino C, Fiscus S, Pahwa S, Fowler M, Spector S . Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children. JAMA. 1998; 279(10):756-61. DOI: 10.1001/jama.279.10.756. View

Izquierdo-Useros N, Lorizate M, McLaren P, Telenti A, Krausslich H, Martinez-Picado J . HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1. PLoS Pathog. 2014; 10(7):e1004146. PMC: 4102576. DOI: 10.1371/journal.ppat.1004146. View

Berraondo P, Sanmamed M, Ochoa M, Etxeberria I, Aznar M, Perez-Gracia J . Cytokines in clinical cancer immunotherapy. Br J Cancer. 2018; 120(1):6-15. PMC: 6325155. DOI: 10.1038/s41416-018-0328-y. View

10.

Hall M, Geyer S, Guo C, Panoskaltsis-Mortari A, Jouvet P, Ferdinands J . Innate immune function and mortality in critically ill children with influenza: a multicenter study. Crit Care Med. 2012; 41(1):224-36. PMC: 3705720. DOI: 10.1097/CCM.0b013e318267633c. View

11.

Hamilton J . GM-CSF-Dependent Inflammatory Pathways. Front Immunol. 2019; 10:2055. PMC: 6737278. DOI: 10.3389/fimmu.2019.02055. View

12.

Rosas M, Gordon S, Taylor P . Characterisation of the expression and function of the GM-CSF receptor alpha-chain in mice. Eur J Immunol. 2007; 37(9):2518-28. PMC: 2699419. DOI: 10.1002/eji.200636892. View

13.

Lau Y, Tang L, Ooi E, Subbarao K . Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice. Virology. 2010; 406(1):80-7. PMC: 2932846. DOI: 10.1016/j.virol.2010.07.008. View

14.

Achuthan A, Aslam A, Nguyen Q, Lam P, Fleetwood A, Frye A . Glucocorticoids promote apoptosis of proinflammatory monocytes by inhibiting ERK activity. Cell Death Dis. 2018; 9(3):267. PMC: 5833693. DOI: 10.1038/s41419-018-0332-4. View

15.

Hamilton J, Stanley E, Burgess A, Shadduck R . Stimulation of macrophage plasminogen activator activity by colony-stimulating factors. J Cell Physiol. 1980; 103(3):435-45. DOI: 10.1002/jcp.1041030309. View

16.

Subramaniam R, Hillberry Z, Chen H, Feng Y, Fletcher K, Neuenschwander P . Delivery of GM-CSF to Protect against Influenza Pneumonia. PLoS One. 2015; 10(4):e0124593. PMC: 4414562. DOI: 10.1371/journal.pone.0124593. View

17.

Kuwano K, Braciale T, Ennis F . Cytotoxic T lymphocytes recognize a cross-reactive epitope on the transmembrane region of influenza H1 and H2 hemagglutinins. Viral Immunol. 1989; 2(3):163-73. DOI: 10.1089/vim.1989.2.163. View

18.

Bukreyev A, Belyakov I, Berzofsky J, Murphy B, Collins P . Granulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells. J Virol. 2001; 75(24):12128-40. PMC: 116109. DOI: 10.1128/JVI.75.24.12128-12140.2001. View

19.

Dranoff G, Crawford A, Sadelain M, Ream B, Rashid A, Bronson R . Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science. 1994; 264(5159):713-6. DOI: 10.1126/science.8171324. View

20.

Tugal D, Liao X, Jain M . Transcriptional control of macrophage polarization. Arterioscler Thromb Vasc Biol. 2013; 33(6):1135-44. DOI: 10.1161/ATVBAHA.113.301453. View